Patent application number | Description | Published |
20080262078 | Pharmaceutical Compositions - The present invention relates to a process for the preparation of a stable lyophilized form of a water insoluble drug suitable for parenteral use and pharmaceutical compositions comprising such lyophilized form of the drug. | 10-23-2008 |
20090104274 | PROCESS OF MAKING MICROSPHERES - A process for the manufacture of free-flowing uniformly sized micro spheres for the sustained release of therapeutically active ingredient comprising: a) preparing a first dispersed phase comprising a therapeutically active ingredient, a biodegradable polymer and an organic solvent; b) mixing the first dispersed phase with a aqueous phase to form an emulsion; c) spraying the emulsion into a vessel ( | 04-23-2009 |
20090110744 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS - A sustained release microsphere composition comprising—
| 04-30-2009 |
20090123556 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS - The present invention provides a sustained release microsphere composition comprising | 05-14-2009 |
20100137432 | OPHTHALMIC COMPOSITION COMPRISING A PROSTAGLANDIN - The present invention relates to a pharmaceutical composition suitable for ophthalmic use comprising one or more prostaglandin derivatives or salts, a stabilizing amount of polyethylene glycol hydroxystearate and pharmaceutically acceptable vehicle. | 06-03-2010 |
20100163042 | INHALATION DEVICE - The present invention relates to an inhalation-activatable device for administration of medicament in powder form to the respiratory system of a patient. | 07-01-2010 |
20100297244 | NANODISPERSION - The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more taxane derivative, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts. | 11-25-2010 |
20110166101 | MICROPARTICLES - A substantially porous, micro-particle comprising therapeutically effective amounts of tretinoin and ethyl cellulose | 07-07-2011 |
20110275597 | PHARMACEUTICAL COMPOSITION - The present invention relates to a parenteral pharmaceutical composition comprising therapeutically effective amounts of N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid or its salts or its derivatives and tromethamine wherein the composition is stable. | 11-10-2011 |
20120087959 | NANODISPERSION OF A DRUG AND PROCESS FOR ITS PREPARATION - The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more drugs, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts. | 04-12-2012 |
20130267591 | NOVEL OPHTHALMIC COMPOSITIONS - An ophthalmic solution comprising therapeutically effective amount of a prostaglandin or its analog and water soluble excipient(s) dissolved in a pharmaceutically acceptable vehicle, wherein the solution is free of a surfactant. | 10-10-2013 |
20140030352 | NANODISPERSION - The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more taxane derivative, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts. | 01-30-2014 |